New Products

• 2770246-61-0 HSD17B13-IN-32

• 2758802-10-5 HSD17B13-IN-17

• 2776965-41-2 Glucosylceramide synthase-IN-4

• 2777045-35-7 DDABT1

• 2815223-41-5 Cbl-b-IN-9

• 1841502-36-0 BTK-IN-27

• 1421687-31-1 Bcl-2-IN-13

• 2757762-91-5 Antitumor agent-114

• 2142003-75-4 Antifungal agent 48

• 2925547-94-8 USP1-IN-5

• 3025180-36-0 Tubulin inhibitor 44

• 2945983-00-4 TS-IN-2

• 2886007-54-9 STING agonist-19

• 2851454-42-5 SSTR5 antagonist 3

• 1820602-13-8 SR 11023

• 2941310-03-6 S1P1 agonist 6 hemicalcium

• 3033609-84-3 PKMYT1-IN-2

• 332407-28-0 PI5P4K-β-IN-1

• 1686137-02-9 PI3Kδ-IN-13

• 3006905-22-9 PI3K/HDAC-IN-3

• 3024653-17-3 PAR4 antagonist 5

• 2569296-51-9 MIPS-21335

• 2760515-88-4 mG2N001

• 2922514-69-8 MC-VC-PABC-C6-alpha-Amanitin

• 2698389-43-2 JAK kinase-IN-1

• 2409538-60-7 Igermetostat

• 2948772-71-0 IDO1/TDO-IN-6

• 1313603-15-4 ICMT-IN-31

• 1313603-11-0 ICMT-IN-27

• 1313602-95-7 ICMT-IN-13

• 2770247-76-0 HSD17B13-IN-85

• 2770247-32-8 HSD17B13-IN-62

• 863564-24-3 HSD17B13-IN-2

• 2578802-72-7 HPK1-IN-38

• 2955577-14-5 hMAO-B-IN-7

• 881826-17-1 hDHODH-IN-14

• 2912294-90-5 H3B-968

• 2279945-77-4 Glucocerebrosidase-IN-1 hydrochloride

• 2866301-18-8 GGFG-amide-glycol-amide-Exatecan

• 2702262-15-3 G43-C3-TEG

• 601511-07-3 FKBP51-Hsp90-IN-2

• 2833703-79-8 FGFR3-IN-7

• 1346176-20-2 EGFR/HER2-IN-11

• 2922402-03-5 EGFR kinase inhibitor 3

• 2941512-37-2 DosatiLink-1

• 2619531-95-0 DHODH-IN-25

• 327024-84-0 COX-1/2-IN-6

• 2894104-33-5 CDD-1733

• 2815225-12-6 Cbl-b-IN-10

• 2893803-05-7 BLT2 probe 1

• 2858632-01-4 Bcl-2-IN-16

• 1428439-79-5 BChE-IN-20

• 2948340-59-6 Anticancer agent 144

• 1854892-66-2 Antibacterial agent 160

• 2095397-52-5 Antiangiogenic agent 5

• 2753650-84-7 Androgen receptor degrader-3

• 2091887-74-8 ALP/Carbonic anhydrase-IN-1

• 2858785-68-7 Ac-Val-Gln-aIle-Val-aTyr-Lys-NH2

• 2758685-58-2 AChE-IN-44

• 2413991-75-8 (R)-FT709

• 2779507-62-7 β-AR antagonist 2

• 2941498-87-7 SHP2-IN-18

• 2924767-53-1 RXFP1 receptor agonist-3

• 2251709-89-2 PLK1/BRD4-IN-2

• 1030097-65-4 PAT1inh-A0030

• 2819999-00-1 PARP7-IN-18

• 1613336-69-8 OvCHT1-IN-1

• 1429218-68-7 NPI52

• 2925249-49-4 MMP-13-IN-1

• 1496573-83-1 LSD1-IN-29

• 2673176-36-6 JAK-IN-27

• 908856-14-4 ICMT-IN-54

• 1313602-64-0 ICMT-IN-39

• 1313602-85-5 ICMT-IN-34

• 1313602-79-7 ICMT-IN-16

• 2770247-94-2 HSD17B13-IN-89

• 2770246-77-8 HSD17B13-IN-52

• 2912455-14-0 HSD17B13-IN-47

• 2828455-23-6 HPK1-IN-41

• 1418293-39-6 HDAC4-IN-1

• 2978613-03-3 hAChE-IN-7

• 2862791-11-3 FABP4/5-IN-5

• 2935480-17-2 CSF1R-IN-23

• 2755180-37-9 BT424

• 1834513-66-4 Bocodepsin hydrochloride

• 2243669-93-2 BET-IN-14

• 1808288-49-4 BCR-ABL-IN-8

• 2820286-56-2 Anticancer agent 81

• 1219485-46-7 1-Isopropyltryptophan

• 2225109-18-0 17β-HSD10-IN-3

• 2374124-48-6 (R)-Vanzacaftor

• 2033173-00-9 (R)-IDO/TDO-IN-1

• 2739807-18-0 ZL-28-6

• 920845-86-9 Z32439948

• 2410627-32-4 Y18501

• 2763493-94-1 SREBP/SCAP-IN-2

• 2941499-08-5 SHP2-IN-21

• 2847838-67-7 sEH/HDAC6-IN-1

• 2941346-85-4 RXFP1 receptor agonist-6

• 2794904-62-2 Rha-PEG3-SMCC